サハラ以南のアフリカにおける抗レトロウイルスアナーキーの防止
A D Harries1, D S Nyangulu, N J Hargreaves
1National Tuberculosis Control Programme, Community Health Science Unit, Lilongwe, Malawi. adharries@malawi.net
Lancet (London, England)
|August 15, 2001
まとめ
併用抗レトロウイルス治療は,HIV/AIDSの生存率を大幅に改善しますが,課題に直面しています. 終身治療,薬物毒性,および複雑なレジメンは,遵守を妨げ,薬剤耐性および新しい治療法の必要性につながる.
科学分野:
- 医学 医学 医学 医学 医学
- ウイルス学 ウイルス学 ウイルス学
- 薬理学 薬理学とは
背景:
- 併用抗レトロウイルス療法 (cART) は,HIV/AIDSの管理を変革し,工業国における患者の生存率を劇的に改善しました.
- cARTの成功にもかかわらず,長期的なHIV治療と管理に重大な課題が残っています.
- 終身治療の必要性や薬物毒性などの問題は,患者の治療結果に影響を及ぼします.
研究 の 目的:
- HIV/AIDSに対する抗レトロウイルス併用療法における持続的な課題を強調する.
- ウイルスの耐性に対する治療順守の影響を強調するために.
- 新しい治療戦略の必要性を強調する.
主な方法:
- この研究は,HIV/AIDS治療における現在の課題のレビューです.
- 粘着性低下と薬物耐性への貢献要因の分析.
- 既存の抗レトロウイルス薬の限界に関する文献レビュー.
主要な成果:
- HIV治療は,しばしば生涯にわたって行われるため,長期的な管理上の課題が生じます.
- 多くの患者は薬物中毒を経験したり,複雑な投与スケジュールで苦労したりし,遵守に影響を及ぼします.
- 薬剤耐性HIV菌株の出現の主な要因は,不十分な適合性である.
結論:
- 治療の毒性を克服し,治療法を簡素化することは,遵守を改善するために不可欠です.
- 薬剤耐性の発症を防ぐために,アデレンスの問題に対処することが不可欠です.
- 耐性菌株の出現は,新しい抗レトロウイルス薬と組み合わせの開発を必要とする.
関連する概念動画
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


